{"commentary":{"count":51,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":31,"youtube":14,"podcast":6},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02647099\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"ALASCCA","nct_id":"NCT02647099","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=alascca-nct02647099. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1950,"size":"deep","size_rule":"Deep: 41+ commentary sources"},"registry":{"acronym":"ALASCCA","arms":[{"description":"One tablet acetylsalicylic acid (ASA) 160 mg, orally once daily for three years","label":"Aspirin","type":"ACTIVE_COMPARATOR"},{"description":"One tablet placebo orally once daily for three years","label":"Placebo","type":"PLACEBO_COMPARATOR"}],"collaborators":["Uppsala University Hospital","Skane University Hospital"],"completion_date":{"date":"2026-08","type":"ESTIMATED"},"conditions":["Colorectal Cancer"],"enrollment":{"count":626,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"Acetylsalicylic acid","type":"DRUG"},{"name":"Placebo","type":"DRUG"}],"last_update":"2026-03-13","lead_sponsor":"Anna Martling","official_title":"A Randomized Double-blind Placebo-controlled Study With ASA Treatment in Colorectal Cancer Patients With Mutations in the PI3K Signaling Pathway","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2024-08","type":"ACTUAL"},"primary_outcomes":[{"measure":"Time To Recurrence (TTR)","timeFrame":"3 years"}],"references":[{"citation":"Martling A, Hed Myrberg I, Nilbert M, Gronberg H, Granath F, Eklund M, Oresland T, Iversen LH, Haapamaki C, Janson M, Westberg K, Segelman J, Ersson U, Prytz M, Angenete E, Bergstrom R, Mayrhofer M, Glimelius B, Lindberg J; ALASCCA Study Group. Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer. N Engl J Med. 2025 Sep 18;393(11):1051-1064. doi: 10.1056/NEJMoa2504650.","pmid":"40961426","type":"DERIVED"}],"start_date":{"date":"2016-04-07","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Adjuvant Low Dose Aspirin in Colorectal Cancer","url":"https://clinicaltrials.gov/study/NCT02647099"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/alascca-nct02647099"}